Alexandra Arias

Barcelona, CT 08041, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Pembrolizumab-Associated Polyserositis with Eosinophilic Pleural Effusion During Adjuvant Therapy for Clear Cell Renal Cell Carcinoma: A Case Report and Targeted Review.

Pembrolizumab-Associated Polyserositis with Eosinophilic Pleural Effusion During Adjuvant Therapy for Clear Cell Renal Cell Carcinoma: A Case Report and Targeted Review.

Journal: Current oncology (Toronto, Ont.)
Published: April 27, 2026

Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIF.

Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIF.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 01, 2024

A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma.

A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma.

Journal: Molecular cancer therapeutics
Published: March 25, 2022

Activity and Resistance of a Brain-Permeable Paradox Breaker BRAF Inhibitor in Melanoma Brain Metastasis.

Activity and Resistance of a Brain-Permeable Paradox Breaker BRAF Inhibitor in Melanoma Brain Metastasis.

Journal: Cancer research
Published: December 03, 2021

Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment.

Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 24, 2021

Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment.

Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment.

Journal: Nature communications
Published: August 12, 2020

Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma.

Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma.

Journal: Nature communications
Published: June 04, 2020

Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program.

Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program.

Journal: Acta neuropathologica
Published: May 20, 2019

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy.

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy.

Journal: Nature communications
Published: March 28, 2019

The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer.

The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer.

Journal: Cell reports
Published: January 22, 2018

Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases.

Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases.

Journal: Oncotarget
Published: January 16, 2018

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma.

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma.

Journal: Nature communications
Published: March 25, 2015
Showing 1-12 of 12

Last Updated: 09/26/2026